Type your tag names separated by a space and hit enter


Janessa Smith, Pharm.D. BCPS, Paul A. Pham, Pharm.D., BCPS
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID
Dolutegravir is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --



Tivicay: Treatment of HIV-1 infection in combination with other ARV agents in adults and children weighing ≥30 kg

Triumeq: Treatment of HIV-1 infection in adults and children weighing ≥40 kg

Juluca: Treatment of HIV-1 infection as a complete regimen for adult patients already virologically suppressed on stable ART for 6 months and no known resistance to dolutegravir or rilpivirine


Non-occupational post-exposure prophylaxis (nPEP) in combination with other ARV agents

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: September 13, 2018


Smith, Janessa, and Paul A Pham. "Dolutegravir." Johns Hopkins HIV Guide, 2018. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545239/all/Dolutegravir.
Smith J, Pham PA. Dolutegravir. Johns Hopkins HIV Guide. 2018. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545239/all/Dolutegravir. Accessed August 21, 2019.
Smith, J., & Pham, P. A. (2018). Dolutegravir. In Johns Hopkins HIV Guide. Available from https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545239/all/Dolutegravir
Smith J, Pham PA. Dolutegravir [Internet]. In: Johns Hopkins HIV Guide. ; 2018. [cited 2019 August 21]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545239/all/Dolutegravir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Dolutegravir ID - 545239 A1 - Smith,Janessa,Pharm.D. BCPS AU - Pham,Paul,Pharm.D., BCPS Y1 - 2018/09/13/ BT - Johns Hopkins HIV Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545239/all/Dolutegravir DB - Johns Hopkins Guide DP - Unbound Medicine ER -